Introduction {#H1-1-ZOI200614}
============

Universities across the United States are struggling with the question of whether and how to reopen for the fall 2020 semester.^[@zoi200614r1],[@zoi200614r2]^ Residential colleges, with communal living arrangements, shared dining spaces, intimate classrooms, and a population of young adults anxious to socialize, pose a particular challenge. In the absence of an effective vaccine, a proven therapy, and/or sufficient herd immunity, the best hope for reopening campuses in the fall is likely to be a robust strategy of behavior-based prevention combined with regular monitoring to rapidly detect, isolate, and contain new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections when they occur.^[@zoi200614r3]^

Evidence on the available monitoring technologies and their performance is limited and rapidly evolving. The US Food and Drug Administration is currently evaluating more than 100 candidate tests that screen for the presence of SARS-CoV-2 infection or antibodies.^[@zoi200614r4]^ There are many uncertainties, including the logistics of deployment; the ease and comfort of sample collection; and the accuracy, scalability, turnaround time, and cost of test kits. After a new coronavirus disease 2019 (COVID-19) case is detected, further questions emerge regarding how to conduct subsequent tracing; how to isolate detected cases in the context of congregate housing arrangements; and how to protect other at-risk populations, including faculty, staff, and members of the surrounding community.^[@zoi200614r5]^ These uncertainties underscore the pressing need for both a generalized assessment of population-wide screening for SARS-CoV-2 and a comprehensive plan for reopening universities.

For many US colleges, COVID-19 poses an existential threat: either they open their doors to students in September or they suffer severe financial consequences.^[@zoi200614r6]^ University administrators struggling with this dilemma must nevertheless keep in mind that their first priority is the safety of the students in their care. We offer specific recommendations on the design of a virologic monitoring program that will keep students safe at an affordable cost. Our specific research objectives were, first, to define the minimum performance attributes of a SARS-CoV-2 monitoring program (eg, frequency, sensitivity, specificity, and cost) that could ensure that college students are kept safe; second, to understand how those minimum performance standards might change under varying assumptions about the severity of the epidemic and the success of behavioral and social distancing interventions; third, to suggest what isolation and treatment capacity would need to be in place; and fourth, to forecast what testing might cost and to help decision-makers understand that information to address the question of a screening and monitoring program's value.

Methods {#H1-2-ZOI200614}
=======

Study Design {#H2-1-ZOI200614}
------------

We adapted a simple compartmental epidemic model to capture the essential features of the situation facing university decision-makers that included the epidemiology of SARS-CoV-2; the natural history of COVID-19 illness; and regular mass screening to detect, isolate, and contain the presence of SARS-CoV-2 in a residential college setting (eFigure 1 in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}). A spreadsheet implementation of the model permitted us to vary critical epidemic parameters and to examine how different test performance attributes (ie, frequency, sensitivity, specificity, and cost) would translate to outcomes. Model input data ([Table 1](#zoi200614t1){ref-type="table"})^[@zoi200614r7],[@zoi200614r8],[@zoi200614r9],[@zoi200614r10],[@zoi200614r11],[@zoi200614r12],[@zoi200614r13],[@zoi200614r14],[@zoi200614r15],[@zoi200614r16],[@zoi200614r17],[@zoi200614r18],[@zoi200614r19]^ were obtained from a variety of published sources, adhering whenever possible to the data guidance for modelers recently issued by the US Centers for Disease Control and Prevention and the Office of the Assistant Secretary for Preparedness and Response. We defined 3 increasingly pessimistic epidemic scenarios and estimated both cumulative outcomes (eg, tests administered, number of true-positive and false-positive results, number of new infections, and person-days requiring isolation) and economic performance (eg, cost, incremental cost-effectiveness, and budget impact) during an abbreviated 80-day semester, running from Labor Day through Thanksgiving.^[@zoi200614r2]^ We assumed a medium-sized college setting with a target population of 5000 students, all of them younger than 30 years and nonimmune, living in a congregate setting.^[@zoi200614r19],[@zoi200614r20]^ We seeded this population with 10 undetected, asymptomatic cases of SARS-CoV-2 infection. A publicly accessible version of the model implementation is available [online](https://docs.google.com/spreadsheets/d/1otD4h-DpmAmh4dUAM4favTjbsly3t5z-OXOtFSbF1lY/edit#gid=1783644071).

###### Model Input Parameters and Scenarios

  Model parameter                               Input               References
  --------------------------------------------- ------------------- -------------------------------------------------------------------------------------------------
  Compartments in initial population, No.                           
  Noninfected, susceptible                      4990                US News and World Report,^[@zoi200614r19]^ 2020
  Infected, asymptomatic                        10                  Assumption
  All other compartments                        0                   Assumption
  Time horizon, d                               80                  Hubler,^[@zoi200614r2]^ 2020
  Disease dynamics                                                  
  Mean incubation time, θ                       3 d                 He et al,^[@zoi200614r8]^ 2020
  Time to recovery, 1/ρ                         14 d                Lauer et al,^[@zoi200614r10]^ 2020; CDC,^[@zoi200614r11]^ 2020
  Time to false-positive return, 1/μ            1 d                 Assumption
  Probability of symptoms given infection, %    30                  Day,^[@zoi200614r12]^ 2020; Yang et al,^[@zoi200614r13]^ 2020; Ing et al,^[@zoi200614r14]^ 2020
  Symptomatic case fatality ratio, %            0.05                CDC,^[@zoi200614r7]^ 2020
  Transmission rate, β                          Dependent on R~t~   NA
  Rate of symptom development, σ                Dependent on R~t~   NA
  Scenarios                                                         
  Effective R~t~                                                    
  Best                                          1.5                 CDC,^[@zoi200614r7]^ 2020; Pitzer et al,^[@zoi200614r15]^ 2020; Li et al,^[@zoi200614r16]^ 2020
  Base                                          2.5                 
  Worst                                         3.5                 
  Test specificity, ie, true-negative rate, %                       
  Best                                          99.7                Lieberman et al^[@zoi200614r17]^ 2020; Zhen et al,^[@zoi200614r18]^ 2020
  Base                                          98.0                
  Worst                                         98.0                
  Exogenous infections per wk, No.                                  
  Best                                          5                   Assumption
  Base                                          10                  
  Worst                                         25                  
  Test characteristics                                              
  Sensitivity, ie, true-positive rate, %                            
  Test I                                        70                  Assumption
  Test II                                       80                  
  Test III                                      90                  
  Cost per test, \$                                                 
  Test I                                        10                  Assumption
  Test II                                       25                  
  Test III                                      50                  
  Time to test result return, h                 8                   Assumption
  Confirmatory test                                                 
  Sensitivity, %                                100                 Assumption
  Cost, \$                                      100                 Assumption

Abbreviations: CDC, US Centers for Disease Control and Prevention; NA, not applicable; R~t~, reproduction number.

This analysis adheres to the Consolidated Health Economic Evaluation Reporting Standards ([CHEERS](http://www.equator-network.org/reporting-guidelines/cheers/)) reporting guideline, where applicable. Because this study used only aggregate, published data, the institutional review boards of both the Massachusetts General Hospital and the Yale School of Medicine determined that this research did not involve human participants and did not require their review or approval.

Compartmental Model {#H2-2-ZOI200614}
-------------------

To the basic susceptible-exposed-infected-removed compartmental modeling framework, we added the following: the availability of regular, repeated screening with a test of imperfect sensitivity and specificity; the creation of a new compartment for uninfected persons receiving a false-positive test result; separation of the infected compartment to distinguish between asymptomatic patients with undetected infection, asymptomatic patients with detected infection (ie, true-positives), and observed symptomatic patients; and the importation of additional new infections via exogenous shocks (eg, infections transmitted to students by university employees or members of the surrounding community or during superspreader events, such as parties).

We defined 3 epidemic severity scenarios: a base case with a reproduction number (R~t~) of 2.5, test specificity of 98%, and the exogenous introduction of 10 new, undetected infections to the susceptible population each week; a worst case with an R~t~ of 3.5, test specificity of 98%, and 25 exogenous new infections every week; and a best case with an R~t~of 1.5, test specificity of 99.7%, and 5 exogenous new infections each week.

Isolation {#H2-3-ZOI200614}
---------

We assumed that after a lag of 8 hours, individuals receiving a positive test result (true or false) and those exhibiting COVID-19 symptoms would be moved from the general population to an isolation dormitory, where their infection would be confirmed, where they would receive supportive care, and from which no further transmissions would occur. The lag reflected both test turnaround delays and the time required to locate and isolate identified cases. Students with confirmed (ie, true-positive) results would remain in the isolation dormitory a mean of 14 days to ensure they were not infectious before proceeding to a recovered or immune state.^[@zoi200614r10],[@zoi200614r11]^ Students with false-positive results would remain isolated for 24 hours, reflecting our assumption that a highly specific confirmatory test could overturn the original diagnosis, permitting them to return to the campus population.

We assumed a mean time from exposure to both infectiousness and screening detectability of 3 days, a symptomatic case fatality risk of 0.05%, and a 30% probability that infection would eventually lead to observable COVID-19--defining symptoms in this young cohort.^[@zoi200614r7],[@zoi200614r8],[@zoi200614r9],[@zoi200614r12],[@zoi200614r13],[@zoi200614r14]^

Screening {#H2-4-ZOI200614}
---------

We sought to evaluate both existing SARS-CoV-2 detection methods and newer technologies that could plausibly be available in the near future. Accordingly, we considered a range of different test sensitivities (ie, 70%-99%), specificities (ie, 98%-99.7%),^[@zoi200614r17],[@zoi200614r18]^ and per-test costs (ie, \$10-\$50). For each combination of these test characteristics, we considered both symptom-based screening and routine testing every 1, 2, 3, and 7 days. We assumed that a confirmatory test with 100% specificity could distinguish false-positive from true-positive results at a cost of \$100.

Cost-effectiveness {#H2-5-ZOI200614}
------------------

Next, we estimated incremental cost-effectiveness ratios, denominated in screening costs per infection averted. This measure of return on investment in screening was compared with a crude benchmark of value estimated using the following 4 terms: (1) COVID-related mortality (0.05% in persons of college age; 0.4% overall)^[@zoi200614r7]^; (2) survival loss of 60 years per college-age fatality; 20 years overall^[@zoi200614r21]^; (3) societal willingness-to-pay (WTP) threshold of \$100 000 per year of life gained^[@zoi200614r22]^; and (4) R~t~ + 1, assuming that each infection averted prevents half the R~t~ secondary infections among college-age students and half among other adult members of the campus community.^[@zoi200614r7],[@zoi200614r15],[@zoi200614r16]^ This method yielded a maximum WTP to avert 1 infection of \$5500 in the best case, \$8500 in the base case, and \$11 600 in the worst case.

Cost-effectiveness analysis identified a preferred screening strategy from among 13 possibilities---3 test sensitivities (70%, 80%, and 90%) and 4 frequencies (1, 2, 3, and 7 times per week) in addition to symptom-based screening---under each epidemic scenario (base, worst, and best cases) already described. We also considered the more restricted case, in which the only available test cost \$25 and had a sensitivity of 80%. Finally, to help decision-makers understand the fiscal consequences of pursuing these preferred strategies, we conducted a budget impact assessment, reporting the cumulative costs for the semester on a per-student basis.

Statistical Analysis {#H2-6-ZOI200614}
--------------------

The model was implemented as a spreadsheet. All analyses were conducted in Microsoft Excel. Because no statistical tests were run, no prespecified level of statistical significance was set.

Results {#H1-3-ZOI200614}
=======

Test Frequency and Sensitivity {#H2-7-ZOI200614}
------------------------------

At the start of the semester, the hypothetical cohort of 5000 students included 4990 (99.8%) with no SARS-CoV-2 infection and 10 (0.2%) with SARS-CoV-2 infection. During an 80-day semester in the base case (ie, R~t~ of 2.5 and 10 exogenous infections each week), screening every 1, 2, 3, or 7 days with a 70% sensitive, 98% specific test resulted in 162, 243, 379, and 1840 cumulative infections, respectively. Symptom-based screening yielded 4970 infections. Raising the sensitivity of the test from 70% to 90% reduced total infections (eg, from 162 to 149 for daily screening and from 1840 to 1118 for weekly screening). [Figure 1](#zoi200614f1){ref-type="fig"} shows cumulative infections as a function of test sensitivity and test frequency for the 3 epidemic severity scenarios.

![Cumulative Infections as a Function of Test Sensitivity and Frequency\
During an 80-day horizon, for the base case (R~t~ of 2.5, test specificity of 98%, and 10 exogenous infections per week) (A), worst case (R~t~ of 3.5, test specificity of 98%, and 25 exogenous infections per week) (B), and best case (R~t~ of 1.5, test specificity of 99.7%, and 5 exogenous infections per week) (C), these panels report cumulative infections for tests with sensitivity ranging from 70% to 99%.](jamanetwopen-3-e2016818-g001){#zoi200614f1}

Isolation Dormitory Occupancy {#H2-8-ZOI200614}
-----------------------------

In the base case, daily screening with a 70% sensitive, 98% specific test resulted in a mean isolation dormitory census of 116 occupants, of whom 21 (18%) had true-positive results ([Figure 2](#zoi200614f2){ref-type="fig"}A). With screening every 2 days, mean daily census was reduced to 76, as fewer tests were performed and fewer false-positive results were obtained; however, less frequent testing was also associated with greater transmission of infection and a higher mean proportion of students with true-positive results in isolation (28 students \[37%\]) ([Figure 2](#zoi200614f2){ref-type="fig"}B). Weekly and symptom-based screening were associated with large increases in the infected occupancy of the isolation dormitory ([Figure 2](#zoi200614f2){ref-type="fig"}C and [Figure 2](#zoi200614f2){ref-type="fig"}D). For example, screening every 7 days resulted in a mean daily isolation census of 121 students, with 108 (90%) with true-positive results. Sensitivity analysis revealed that the trends evident in [Figure 2](#zoi200614f2){ref-type="fig"} extended beyond the 80-day planning horizon (data not shown). Varying the initial number of asymptomatic infections between 0 and 100 did not materially change our findings.

![Projecting the Required Size of the Isolation Dormitory\
An isolation dormitory needs to be large enough to house students with false-positive results, students with symptoms, and students without symptoms who have received true-positive results. During the 80-day horizon, these panels depict the number of students in the isolation dormitory using a 70% sensitive, 98% specific test under the base case scenario (ie, R~t~ of 2.5). The effect of exogenous shocks (10 per week) is visible in the scalloped borders with daily screening and screening every 2 days (A, B); this is less evident with less frequent testing and symptom-based screening (C, D), in which the number of true-positive cases masks the comparatively small effect of exogenous shocks.](jamanetwopen-3-e2016818-g002){#zoi200614f2}

The number of students with false-positive results and the isolation capacity required to accommodate them were reduced in the presence of a more specific test. For example, with daily screening in the base case, increasing the test specificity from 98% to 99.7% was associated with a decrease in the mean daily census of students with false-positive results in isolation from 95 to 15.

Under worst-case assumptions (ie, R~t~ of 3.5 with 25 exogenous infections every week), daily screening yielded mean isolation dormitory census of 152 students, of whom 60 (39%) had true infections (eFigure 2A in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}). Screening every 2 days produced similar census (151) but a higher proportion (106 \[70%\]) of true infections (eFigure 2B in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}). With weekly screening or symptom-based screening, nearly the entire student population would be infected before the conclusion of the 80-day semester (eFigure 2C and eFigure 2D in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}).

In the best case (ie, R~t~ of 1.5 with 5 exogenous shocks each week and a test with 99.7% specificity), mean occupancy of the isolation dormitory was 18 (16 with infection; 2 with false-positive results) with weekly screening and 24 (all true infections) with symptom-based screening (eFigure 3 in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}).

Cost-effectiveness and Budget Impact Assessment {#H2-9-ZOI200614}
-----------------------------------------------

In the base case, screening with a less expensive, less sensitive test dominated screening with more expensive, more accurate tests (ie, it cost less and averted greater numbers of infection) for all plausible WTP values. At the benchmark maximum WTP (\$8500 per infection averted), screening every 2 days with a 70% sensitive test was the preferred strategy. For WTP exceeding \$28 400 per infection averted, daily screening with this same test was optimal ([Table 2](#zoi200614t2){ref-type="table"}). Under worst-case assumptions, daily screening strategies were the only undominated choices for WTP values exceeding \$4400 per infection averted; at the benchmark maximum WTP (\$11 600 per infection averted), daily screening with the least sensitive (ie, 70%) test was the preferred choice. Under best-case assumptions (with a WTP maximum of \$5500 per infection averted), weekly screening with a 70% sensitive test was optimal. If the only available test cost \$25 and had a sensitivity of 80%, the optimal frequency of screening would be every 7, 3, and 2 days in the best, base, and worst case scenarios, respectively (eAppendix and eTable 1 in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}). If the probability of progressing from infection to symptoms rose from 30% to 65%, screening every day would be optimal in the base case scenario (eTable 2 in the [Supplement](#note-ZOI200614-1-s){ref-type="supplementary-material"}). During the 80-day semester, the per-student costs of implementing the preferred screening strategy were \$120, \$470, and \$910 in the best, base, and worst case scenarios, respectively ([Table 3](#zoi200614t3){ref-type="table"}).

###### Results of the Incremental Cost-effectiveness Analysis in the Base-Case, Worst-Case, and Best-Case Scenarios

  Frequency                                                           Test sensitivity, %   Cost, \$     Total infections   Incremental cost-effectiveness ratio, \$/infection averted[^a^](#zoi200614t2n1){ref-type="table-fn"}
  ------------------------------------------------------------------- --------------------- ------------ ------------------ ------------------------------------------------------------------------------------------------------
  **Base-case scenario**[^b^](#zoi200614t2n2){ref-type="table-fn"}                                                          
  Symptom-based screening                                             NA                    NA           4970               NA
  Weekly                                                              70                    696 000      1840               200
  Weekly                                                              80                    1 490 700    1422               Dominated
  Every 3 d                                                           70                    1 564 500    379                600
  Every 2 d                                                           70                    2 340 600    243                5700
  Weekly                                                              90                    2 837 500    1118               Dominated
  Every 3 d                                                           80                    3 501 800    319                Dominated
  Daily                                                               70                    4 642 700    162                28 400
  Every 2 d                                                           80                    5 254 900    219                Dominated
  Every 3 d                                                           90                    6 740 400    280                Dominated
  Every 2 d                                                           90                    10 118 700   202                Dominated
  Daily                                                               80                    10 440 000   154                752 600
  Daily                                                               90                    20 106 900   149                1 692 900
  **Worst-case scenario**[^c^](#zoi200614t2n3){ref-type="table-fn"}                                                         
  Symptom-based screening                                             NA                    NA           4991               NA
  Weekly                                                              70                    673 600      4991               Dominated
  Weekly                                                              80                    1 274 200    4988               Dominated
  Every 3 d                                                           70                    1 509 300    2373               Dominated
  Every 2 d                                                           70                    2 266 400    998                600
  Weekly                                                              90                    2 310 000    4951               Dominated
  Every 3 d                                                           80                    3 292 800    1731               Dominated
  Daily                                                               70                    4 543 900    481                4400
  Every 2 d                                                           80                    5 063 200    814                Dominated
  Every 3 d                                                           90                    6 347 900    1335               Dominated
  Every 2 d                                                           90                    9 764 100    701                Dominated
  Daily                                                               80                    10 207 500   445                159 700
  Daily                                                               90                    19 666 200   420                377 500
  **Best-case scenario**[^d^](#zoi200614t2n4){ref-type="table-fn"}                                                          
  Symptom-based screening                                             NA                    NA           1067               NA
  Weekly                                                              70                    587 800      188                700
  Every 3 d                                                           70                    1 364 600    103                9100
  Weekly                                                              80                    1 432 700    168                Dominated
  Every 2 d                                                           70                    2 044 500    85                 38 800
  Weekly                                                              90                    2 842 200    152                Dominated
  Every 3 d                                                           80                    3 343 100    96                 Dominated
  Daily                                                               70                    4 080 900    69                 128 100
  Every 2 d                                                           80                    5 013 900    81                 Dominated
  Every 3 d                                                           90                    6 642 100    91                 Dominated
  Every 2 d                                                           90                    9 964 200    78                 Dominated
  Daily                                                               80                    10 016 800   68                 3 156 700
  Daily                                                               90                    19 911 200   66                 6 833 800

Abbreviations: NA, not applicable.

Strategies that cost more and result in more infections than some combination of other strategies are labeled *dominated*.

Base-case scenario had a reproduction number of 2.5, 10 exogenous shock infections each week, and a maximum willingness-to-pay threshold of \$8500 per infection averted.

Worst-case scenario had a reproduction number of 3.5, 25 exogenous shock infections each week, and a maximum willingness-to-pay threshold of \$11 600 per infection averted.

Best-case scenario had a reproduction number of 1.5, 5 exogenous shock infections each week, a test with 99.7% specificity, and a maximum willingness-to-pay threshold of \$5500 per infection averted.

###### Per-Student Costs for Optimal Policies During an 80-Day Horizon Under Base-Case, Worst-Case, and Best-Case Scenarios

  Scenario                      Optimal policy                         Cost per student, \$
  ----------------------------- -------------------------------------- ----------------------
  Base case, ie, R~t~ of 2.5    Screening every 2 d, 70% sensitivity   470
  Worst case, ie, R~t~ of 3.5   Daily screening, 70% sensitivity       910
  Best case, ie, R~t~ of 1.5    Weekly screening, 70% sensitivity      120

Abbreviation: R~t~, reproduction number.

Discussion {#H1-4-ZOI200614}
==========

The safe return of students to residential colleges demands an effective SARS-CoV-2 monitoring strategy. Results from this modelling study suggest that a highly specific screening test that can easily be administered to each student every 1 to 7 days---and that reports results quickly enough to permit newly detected cases to be isolated within hours---would be required to blunt the further transmission of infection and to control outbreaks at a justifiable cost. We identified no circumstance in this modelling study under which symptom-based screening alone would be sufficient to contain an outbreak.

Of the many uncertain variables driving our assessment of the required frequency of screening, we highlight R~t~. This uncertain measure of the transmission potential of infection will depend in part on factors that are within the control of students and university administrators. Strict adherence to handwashing, mandated indoor masking, elimination of buffet dining, limited bathroom sharing with frequent cleaning, dedensifying campuses and classrooms, and other best practices could reduce R~t~ to best-case levels, rendering containment possible with weekly testing. However, any relaxation of these measures in the residential college setting could easily increase R~t~ to worst-case levels, requiring daily screening. All members of the university community must understand the fragility of the situation and the ease with which inattention to behavior may propagate infections and precipitate the need once again to shut down campus.

Much depends on the judicious management of positive test results, both true and false. Rapid detection, confirmation, isolation, and treatment of true-positive cases is, of course, essential. We found that frequent screening with a test of modest sensitivity and a turnaround time of 8 hours would be required for this purpose. The greater difficulty lies in managing the overwhelming number of false-positives that will inevitably result from repeated screening for low-prevalence conditions. False-positive results threaten to overwhelm isolation housing capacity, a danger whose gravity increases with screening frequency. The specificity of the initial test will matter far more than its sensitivity. Many current virologic tests report a 99.8% to 100% specificity in the context of use to date for symptomatic testing^[@zoi200614r23]^; we examined a value of 99.7% in the best case but used a lower value of 98% in the base-case and worst-case scenarios, given that most virologic tests have yet to be used for the kind of large-scale surveillance described in this model.

Even with a 98% specific screening test, false-positive results will present a challenge. Until a confirmatory test result is obtained, anyone receiving a positive test result will be presumed to be infectious and need to be separated from other students. Setting aside the logistic challenges and financial costs, administrators must anticipate the anxiety such separations may provoke among both students and their families. Excessive numbers of false-positive results may fuel panic and undermine confidence in the reliability of the monitoring program. It may be possible to work with test manufacturers to tune test kits under development for use in this setting, sacrificing some small measure of sensitivity in favor of higher specificity.

Obtaining an adequate supply of testing equipment will be a challenge. On a college campus with 5000 enrollees, screening students alone every 2 days will require more than 195 000 test kits during the abbreviated semester. Our analysis assumed per-test costs (including equipment and associated personnel costs) ranging from \$10 to \$50. Lower-cost, self-administered testing modalities may soon be available and could make screening more affordable. Pooling could also facilitate more efficient, higher-volume screening.^[@zoi200614r24]^ However, pooling introduces its own logistic challenges and could increase the time to definitively identifying and isolating a positive case, resulting in further transmission and provoking anxiety among the many uninfected students notified that they are among the members of an initially positive pool.

We have tried to help decision-makers make sense of the value question by conducting a cost-effectiveness analysis and by comparing our findings with a rough estimate of the societal WTP per infection averted.^[@zoi200614r25]^ While we have adhered to the broad outlines of recommended practice for the conduct of economic evaluations,^[@zoi200614r25]^ we urge readers to interpret our results with caution. Most of our assumptions are conservative, ie, they understate the value of more frequent testing. For example, we ignored the clinical harms and attributable costs of COVID-19--related morbidity and treatment. We also ignored the value of infections averted beyond the student population. However, a few assumptions (eg, our failure to account for the economic and quality-of-life effects of false-positive results) may pull in the direction of less testing.

Reopening college campuses imposes risks that extend beyond students to the faculty who teach them, the many university employees (administrative and facilities staff) who come into close daily contact with them, and the countless other members of the surrounding community with whom students come into contact. University presidents have a duty to consider the downstream effect of their reopening decisions on these constituencies. However, their first responsibility is to the safety of the students in their care. While we certainly do not intend to minimize the broader effects of the reopening decision, we have quite deliberately excluded from consideration any transmissions exported off campus.

Limitations {#H2-10-ZOI200614}
-----------

The simple model underlying this analysis has notable limitations. We assumed homogenous mixing without age-dependent transmission. We did not explicitly include the effect of screening on faculty and staff, although these and other nonstudent members of the college community include a higher proportion of older, more medically vulnerable individuals. We assumed that no students arrive on campus with immunity to COVID-19. We excluded the effects of contact tracing. Given its implementation challenges, this is a noteworthy omission. However, our results suggest that with frequent enough screening, contact tracing would not be necessary for epidemic control. While this analysis offers guidance on the frequency of screening, it does not speak to the logistic challenges of deploying testing strategies on large college campuses. Such challenges include the acquisition of supplies; the orchestration of screening at scale; the monitoring of adherence; the development of a strategy for rapid result return, contact, and isolation; and the availability and maintenance of an isolation dormitory with all single rooms and bathrooms.

Conclusions {#H1-5-ZOI200614}
===========

We believe that there is a safe way for students to return to college in fall 2020. In this study, screening every 2 days using a rapid, inexpensive, and even poorly sensitive (\>70%) test, coupled with strict interventions that keep R~t~ less than 2.5, was estimated to yield a modest number of containable infections and to be cost-effective. This sets a very high bar---logistically, financially, and behaviorally---that may be beyond the reach of many university administrators and the students in their care.
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